"10.1371_journal.pone.0038575","plos one","2012-06-13T00:00:00Z","Erhan Bilal; Kristen Vassallo; Deborah Toppmeyer; Nicola Barnard; Inga H Rye; Vanessa Almendro; Hege Russnes; Anne-Lise BÃ¸rresen-Dale; Arnold J Levine; Gyan Bhanot; Shridar Ganesan","Rutgers, The State University of New Jersey, Piscataway, New Jersey, United States of America; Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America; Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States of America; Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway; Dana Farber Cancer Institute, Harvard University, Boston, Massachusetts, United States of America; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain; Institute for Advanced Study, Princeton, New Jersey, United States of America","Conceived and designed the experiments: EB SG GB AB-D. Performed the experiments: EB KV HR IR VA. Analyzed the data: EB HR IR VA SG GB DT NB AL. Contributed reagents/materials/analysis tools: EB DT NB AB-D. Wrote the paper: EB HR GB AB-D SG.","SG is a consultant for Ibris Inc. SG, EB and GB are co-inventors on a patent entitled GENETIC MARKERS AND DIAGNOSTIC METHODS FOR RESISTANCE OF BREAST CANCER TO HORMONAL THERAPIES United States Patent Application Serial No. 13/220,434. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials. The other authors have no competing interests.","2012","06","Erhan Bilal","EB",11,FALSE,4,5,9,5,TRUE,TRUE,FALSE,0,NA,FALSE
